The patient or legally authorized representative must provide study-specific informed consent prior to study entry and, for patients treated in the United States (U.S.), authorization permitting release of personal health information
Patients must have signed an approved informed consent and authorization permitting release of personal health information
Patients must have signed an approved informed consent and authorization permitting release of personal health information
Patients must have signed an approved informed consent and authorization permitting release of personal health information
Patients must have signed an approved informed consent and authorization permitting the release of personal health information
Patients must have signed an approved informed consent and authorization permitting release of personal health information
Patients must have signed an approved informed consent and authorization permitting release of personal health information
PHASE I: Ability to understand and the willingness to sign a written informed consent document; patients must sign an approved informed consent and authorization permitting release of personal health information
PHASE II: Ability to understand and the willingness to sign a written informed consent document; patients must sign an approved informed consent and authorization permitting release of personal health information
Patients must have signed an approved informed consent and authorization permitting release of personal health information
Patients who have signed informed consent and authorization permitting release of personal health information
The patient or a legally authorized representative must provide study-specific informed consent and authorization permitting release of personal health information prior to study entry
The patient must provide study-specific informed consent prior to study entry and, for patients treated in the United States (U.S.), authorization permitting release of personal health information
The patient or a legally authorized representative must provide study-specific informed consent authorization permitting release of personal health information prior to study entry
Patients must have signed an approved informed consent and authorization permitting release of personal health information
Patients must have signed an approved informed consent and authorization permitting release of personal health information
Patients must have signed an approved informed consent and authorization permitting the release of personal health information
Patients must have signed an approved informed consent and authorization permitting release of personal health information
Patients must have signed an approved informed consent and authorization permitting release of personal health information
Patients must have signed an approved informed consent and authorization permitting the release of personal health information
Patients must have the ability to understand and sign an approved informed consent and authorization permitting release of personal health information
Patients must have signed an approved informed consent and authorization permitting release of personal health information; individuals with impaired decision-making capacity are not eligible to participate on the study
Patients participating through United States (U.S.) sites must sign an approved and authorization permitting release of personal health information
Patients must have signed an approved informed consent and authorization permitting release of personal health information
The patient or a legally authorized representative must provide study-specific informed consent and authorization permitting release of personal health information prior to study entry
Patients must have signed an approved informed consent and authorization permitting release of personal health information.
Patients must understand and willingly sign an approved informed consent, and authorization permitting release of personal health information
Patients must have signed an IRB-approved informed consent and authorization permitting release of personal health information.
Be willing and able to provide written informed consent/assent and authorization permitting study-related release of personal health information
Patients must have signed an approved informed consent and authorization permitting the release of personal health information
An approved informed consent and authorization permitting release of personal health information must be signed by patient or guardian
An approved Informed Consent and authorization permitting release of personal health information must be signed by the patient or guardian
Patients must have signed an approved informed consent and authorization permitting release of personal health information
Patients must have signed an approved informed consent and authorization permitting release of personal information
Patients must have signed an approved informed consent and authorization permitting release of personal health information
Study subjects must sign an approved informed consent and authorization permitting release of personal health information
An approved informed consent and authorization permitting release of personal health information must be signed by the patient or guardian
Patients must have signed an approved informed consent and authorization form permitting the release of personal health information
Patients must have signed an approved informed consent and authorization permitting release of personal health information
Patients must have signed an approved informed consent and authorization permitting release of personal health information
Patients must have signed an approved informed consent and authorization permitting release of personal health information
An approved informed consent and authorization permitting release of personal health information must be signed by the patient or guardian
Ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use protected health information (in accordance with national and local subject privacy regulations)
Unable to understand the purpose and risks of the study and to provide a signed and dated informed consent form (ICF) and authorization to use protected health information (in accordance with national and local subject privacy regulations)
Unable to understand the purpose and risks of the study and to provide a signed and dated informed consent form (ICF) and authorization to use protected health information (in accordance with national and local subject privacy regulations)
Unable to understand the purpose and risks of the study and to provide a signed and dated informed consent form (ICF)
The patient or the patientâ€™s legal representative is able to understand the risks of the study and provide signed informed consent and authorization to use protected health information (in accordance with national and local privacy regulations)
Unable to understand the purpose and risks of the study and to provide a signed and dated informed consent form (ICF) and authorization to use protected health information (in accordance with national and local subject privacy regulations)
Voluntarily sign and date an informed consent form (ICF) with authorization to use protected health information (in accordance with national and local subject privacy regulations) and approved by the Institutional Review Board (IRB) prior to initiation of any study specific procedures
Unable to understand the purpose and risks of the study and to provide a signed and dated informed consent for (ICF) and authorization to use protected health information (in accordance with national and local subject privacy regulations)
Unable to understand the purpose and risks of the study and to provide a signed and dated informed consent form (ICF) and authorization to use protected health information (in accordance with national and local subject privacy regulations)
Unwilling or unable to participate in all required study evaluations and procedures or unable to understand the purpose and risks of the study and to provide a signed and dated informed consent form (ICF) and authorization to use protected health information (in accordance with national and local subject privacy regulations)
Unable to understand the purpose and risks of the study and to provide a signed and dated informed consent form (ICF) and authorization to use protected health information (in accordance with national and local subject privacy regulations)
Ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use protected health information (in accordance with national and local subject privacy regulations)
Unable to understand the purpose and risks of the study and to provide a signed and dated informed consent form (ICF) and authorization to use protected health information (in accordance with national and local subject privacy regulations)
Unable to understand the purpose and risks of the study and to provide a signed and dated informed consent form (ICF) and authorization to use protected health information (in accordance with national and local subject privacy regulations)
Unwilling or unable to participate in all required study evaluations and procedures; unable to understand the purpose and risks of the study and to provide a signed and dated informed consent form (ICF) and authorization to use protected health information (in accordance with national and local subject privacy regulations)
Ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use protected health information (in accordance with national and local patient privacy regulations).
Unwilling or unable to participate in all required study evaluations and procedures or unable to understand the purpose and risks of the study and to provide a signed and dated informed consent form (ICF) and authorization to use protected health information (in accordance with national and local subject privacy regulations)
Patient or appointed surrogate decision-maker or legally authorized representative must have ability to understand the purpose and risks of the study and willingness to provide a signed and dated informed consent form (ICF) and authorization to use protected health information (in accordance with national and local subject privacy regulations)
Unable to understand the purpose and risks of the study and to provide a signed and dated informed consent form (ICF) and authorization to use protected health information (in accordance with national and local subject privacy regulations)
Unable to understand the purpose and risks of the study and to provide a signed and dated informed consent form (ICF) and authorization to use protected health information (in accordance with national and local subject privacy regulations)
Ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use protected health information (in accordance with national and local subject privacy regulations).
Ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use protected health information (PHI) in accordance with national and local subject privacy regulations
Unable to understand the purpose and risks of the study and to provide a signed and dated informed consent form (ICF) and authorization to use protected health information (in accordance with national and local subject privacy regulations)
Unable to understand the purpose and risks of the study and to provide a signed and dated informed consent form (ICF) and authorization to use protected health information (in accordance with national and local subject privacy regulations)
Unable to understand the purpose and risks of the study and to provide a signed and dated informed consent form (ICF) and authorization to use protected health information (in accordance with national and local subject privacy regulations).
Ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use protected health information (in accordance with national and local subject privacy regulations
Able to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use protected health information (in accordance with national and local subject's privacy regulations).
Unable to understand the purpose and risks of the study and to provide a signed and dated informed consent form (ICF) and authorization to use protected health information (in accordance with national and local subject privacy regulations)
Unable to understand the purpose and risks of the study and to provide a signed and dated informed consent form (ICF) and authorization to use protected health information (in accordance with national and local subject privacy regulations)
Patient is unable to understand the purpose and risks of the study and to provide a signed and dated informed consent form (ICF) and authorization to use protected health information (PHI) in accordance with national and local subject privacy regulations; a legal representative can consent on behalf of a patient who is able to understand the purpose and risk of the study but not able to provide a signature on the ICF and authorization to use PHI due to neurologic deficits (e.g. motor or language deficits)
EXCLUSION CRITERIA (PRIOR TO IBRUTINIB ADMINISTRATION): Unable to understand the purpose and risks of the study and to provide a signed and dated informed consent form (ICF) and authorization to use protected health information (in accordance with national and local subject privacy regulations)
Unwilling or unable to participate in all required study evaluations and procedures; unable to understand the purpose and risks of the study and to provide a signed and dated informed consent form (ICF) and authorization to use protected health information (in accordance with national and local subject privacy regulations)
Written informed consent and authorization for release of personal health information obtained according to local laws.
Written authorization for use and release of health and research study information has been obtained.
Written authorization for use and release of health and research study information has been obtained
Signed informed consent form (ICF) providing agreement to adhere to the dosing schedule, report for all trial visits and authorization, use and release of health and research trial information
Signed informed consent form (ICF) providing agreement to adhere to the dosing schedule, report for all trial visits and authorization, use and release of health and research trial information
Signed and witnessed informed consent and signed authorization for the release of their protected health information
Able and willing to provide written authorization for use and release of health and research study information
Written informed consent and authorization for release of personal health information obtained according to local laws.
Provided written authorization for use and release of health and research study information.
Signed informed consent form (ICF) providing agreement to adhere to the dosing schedule, report for all trial visits and authorization, use and release of health and research trial information
Written authorization for use and release of health and research study information has been obtained
Participants must have agreed to and signed an authorization for the release of their protected health information
Written authorization for use and release of health and research study information (United States [US] sites only) has been obtained
Written Authorization for Use and Release of Health and Research Study Information (United States [US] sites only) has been obtained
Written Authorization for Use and Release of Health and Research Study Information has been obtained
Informed consent and authorization for the release of health information signed by the patient
Patients must have signed an authorization for the release of their protected health information.
Signed informed consent form (ICF) providing agreement to adhere to the dosing schedule, report for all trial visits and authorization, use and release of health and research trial information
Written authorization for use and release of health and research study information has been obtained
Written authorization for use and release of health and research study information has been obtained
Patients must sign study-specific informed consent and authorization for the release of their protected health information prior to registration; patients must be registered in the prior to treatment with study drug
Written authorization for use and release of health and research study information has been obtained
Patients must sign an authorization for the release of their protected health information
Able to provide written informed consent and authorization for release of health information
Signed HIPAA compliant research authorization (or equivalent for international sites) to release Personal Health Information to the SunCoast CCOP Research Base must be obtained prior to registration
Written authorization for use and release of health and research study information has been obtained
Written informed consent and authorization to use and disclose health information
Subject consent and authorization for the release of health information must be obtained according to local institutional guidelines
Patient must provide written authorization to allow the use and disclosure of their protected health information; NOTE: This may be obtained in either the study-specific informed consent or in a separate authorization form and must be obtained from the patient prior to study registration
Ability to understand the purpose and risks of the study and provide signed and dated informed consent.
Ability to understand the purpose and risks of the study and provide signed and dated informed consent
Ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use protected health information
Unable to understand the purpose and risks of the study
Ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use protected health information (PHI)
Ability to understand the requirements of the study, provide written informed consent and authorization of use and disclosure of protected health information, and agree to abide by the study restrictions and return for the required assessments
Understand the study purpose, requirements, and risks
Have the ability to understand the requirements of the study, provide written informed consent which includes authorization for release of protected health information, abide by the study restrictions, and agree to return for the required assessments.
Ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use protected health information
Have the ability to understand the requirements of the study, provide written informed consent, which includes authorization for release of protected health information, abide by the study restrictions, and agree to return for the required assessments.
Ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use protected health information
Ability to understand the requirements of the study, provide written informed consent and authorization of use and disclosure of protected health information, and agree to abide by the study restrictions and return for the required assessments
Ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use protected health information (PHI)
Ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use protected health information
Ability to understand the purpose and risks of the study.
Ability to understand the requirements of the study, provide written informed consent and authorization of use and disclosure of protected health information, and agree to abide by the study restrictions and return for the required assessments
Ability to understand the requirements of the study, provide written informed consent and authorization of use and disclosure of protected health information, and agree to abide by the study restrictions and to return for the required assessments.
Ability to understand the requirements of the study, provide written informed consent and authorization of use and disclosure of protected health information, and agree to abide by the study restrictions and to return for required assessments.
Have the ability to understand the requirements of the study, provide written informed consent which includes authorization for release of protected health information, abide by the study restrictions, and agree to return for the required assessments.
Ability to understand the requirements of the study, provide written informed consent and authorization of use and disclosure of protected health information, and agree to abide by the study restrictions and to return for the required assessments
Ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use protected health information
Who are scheduled to undergo laparoscopy and pre-authorized to undergo laparotomy for the debulking surgery if cancer is detected on the laparoscopy 3. A negative serum pregnancy test at Screening followed by a negative urine pregnancy test on the day of surgery or day of admission for female patients of childbearing potential 4. Female patients of childbearing potential or less than 2 years postmenopausal agree to use an acceptable form of contraception from the time of signing informed consent until 30 days after study completion 5. Ability to understand the requirements of the study, provide written informed consent for participation in the study and authorization of use and disclosure of protected health information, and agree to abide by the study restrictions and to return for the required assessments
Ability to understand the requirements of the study, provide written informed consent and authorization of use and disclosure of protected health information, and agree to abide by the study restrictions and to return for the required assessments
Ability to understand purpose and risks of the study and provide signed and dated informed consent, and authorization to use protected health information
